Hasan, Baktiar <br/><br/>
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Nov 2014 
 - 2771-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2014.07.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Europe<br/>Female<br/>Humans<br/>Lung Neoplasms--mortality<br/>Male<br/>Mesothelioma--mortality<br/>Mesothelioma, Malignant<br/>Middle Aged<br/>Pleural Neoplasms--mortality<br/>Prognosis<br/>Reproducibility of Results<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult